ICD-10: B71.1

Dipylidiasis, classified under ICD-10 code B71.1, is a parasitic infection caused by the tapeworm Dipylidium caninum, primarily affecting humans and animals, particularly dogs and cats. This condition is often associated with the ingestion of infected fleas, which serve as intermediate hosts for the tapeworm. Understanding the standard treatment approaches for dipylidiasis is crucial for effective management and prevention.

Diagnosis of Dipylidiasis

Before treatment can begin, accurate diagnosis is essential. Diagnosis typically involves:

• Clinical Evaluation: Patients may present with symptoms such as abdominal discomfort, diarrhea, or the presence of proglottids (tapeworm segments) in the stool.
• Stool Examination: Microscopic examination of stool samples can reveal eggs or proglottids, confirming the presence of Dipylidium caninum.

Standard Treatment Approaches

1. Pharmacological Treatment

The primary treatment for dipylidiasis involves the use of anthelmintic medications. The following drugs are commonly prescribed:

• Praziquantel: This is the most effective treatment for tapeworm infections, including dipylidiasis. It works by causing severe spasms and paralysis of the worms, leading to their expulsion from the host's body.
• Niclosamide: Another effective anthelmintic, niclosamide disrupts the energy metabolism of the tapeworm, leading to its death. It is less commonly used than praziquantel but can be effective in certain cases.

2. Management of Flea Infestation

Since dipylidiasis is often contracted through flea ingestion, managing flea populations is crucial:

• Flea Control: Implementing a comprehensive flea control program for pets is essential. This may include topical treatments, oral medications, and environmental control measures to reduce flea populations in the home.
• Education: Educating pet owners about the life cycle of fleas and the importance of regular flea prevention can help reduce the incidence of dipylidiasis.

3. Symptomatic Treatment

In cases where patients experience significant symptoms, supportive care may be necessary:

• Hydration: Ensuring adequate hydration, especially if diarrhea is present, is important for recovery.
• Nutritional Support: A balanced diet may be recommended to help restore health and energy levels.

Follow-Up and Prevention

After treatment, follow-up is important to ensure the infection has been cleared:

• Repeat Stool Examination: A follow-up stool test may be conducted to confirm the absence of tapeworms.
• Preventive Measures: Continued flea control and regular veterinary check-ups for pets can help prevent reinfection.

Conclusion

Dipylidiasis, while often asymptomatic, can lead to discomfort and complications if left untreated. The standard treatment involves effective anthelmintic medications, flea control measures, and supportive care as needed. By addressing both the infection and its source, healthcare providers can help ensure successful management and prevention of this parasitic disease. Regular follow-ups and education on flea prevention are key components in reducing the risk of recurrence.

Dipylidiasis, classified under ICD-10 code B71.1, refers to an infection caused by the tapeworm Dipylidium caninum, which is primarily transmitted through fleas. Understanding the alternative names and related terms for this condition can enhance clarity in medical documentation and communication. Here’s a detailed overview:

Alternative Names for Dipylidiasis

1. Flea Tapeworm Infection: This name highlights the primary vector (fleas) responsible for the transmission of the infection.
2. Dipylidium Infection: A more general term that refers to infections caused by the Dipylidium genus, which includes Dipylidium caninum.
3. Dog Tapeworm: Since Dipylidium caninum is commonly found in dogs, this term is often used in veterinary contexts.
4. Cat Tapeworm: Similar to the dog tapeworm, this term is used when referring to the infection in cats, which can also serve as hosts for the parasite.

Related Terms

1. Cestodiasis: A broader term that refers to infections caused by cestodes (tapeworms), which includes dipylidiasis as a specific type.
2. Helminthiasis: This term encompasses infections caused by helminths (parasitic worms), including both cestodes and other types of worms.
3. Zoonotic Infection: Since dipylidiasis can be transmitted from animals (like dogs and cats) to humans, it falls under the category of zoonotic infections.
4. Intestinal Parasite Infection: A general term that can include various types of parasitic infections affecting the intestines, including dipylidiasis.

Conclusion

Understanding the alternative names and related terms for ICD-10 code B71.1 (Dipylidiasis) is essential for accurate diagnosis, treatment, and communication in both human and veterinary medicine. These terms not only facilitate better understanding among healthcare professionals but also aid in patient education regarding the nature of the infection and its transmission.

Dipylidiasis, caused by the tapeworm Dipylidium caninum, is a rare parasitic infection primarily affecting humans through the ingestion of infected fleas. The diagnosis of dipylidiasis is based on a combination of clinical evaluation, patient history, and laboratory tests. Below are the key criteria used for diagnosing this condition, particularly in the context of the ICD-10 code B71.1.

Clinical Presentation

1. Symptoms: Patients may present with gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, or vomiting. However, many cases are asymptomatic, which can complicate diagnosis[1].

2. History of Exposure: A thorough patient history is crucial. This includes inquiries about potential exposure to fleas, particularly in individuals with pets, as fleas are the primary vector for transmission[1].

Laboratory Diagnosis

1. Stool Examination: The definitive diagnosis of dipylidiasis is made through the identification of Dipylidium caninum eggs or proglottids in the stool. A stool sample is typically examined microscopically, where the characteristic egg packets can be observed[1][2].

2. Serological Tests: While not commonly used, serological tests may be employed in some cases to detect antibodies against the parasite, although these are not standard practice for dipylidiasis[2].

3. Imaging Studies: In rare cases where complications arise, imaging studies such as ultrasound or CT scans may be utilized to assess for any associated complications, although these are not routine for diagnosis[1].

Differential Diagnosis

It is essential to differentiate dipylidiasis from other gastrointestinal infections and parasitic diseases. Conditions such as other types of tapeworm infections (e.g., Taenia species) and gastrointestinal disorders should be considered and ruled out through appropriate testing and clinical evaluation[2].

Conclusion

In summary, the diagnosis of dipylidiasis (ICD-10 code B71.1) relies heavily on clinical symptoms, patient history, and laboratory findings, particularly stool examinations for the presence of the parasite's eggs or proglottids. Given the potential for asymptomatic cases, awareness of risk factors, such as flea exposure, is critical in guiding diagnosis and treatment. If you suspect dipylidiasis, it is advisable to consult a healthcare professional for appropriate testing and management.

Dipylidiasis, classified under ICD-10-CM code B71.1, is a parasitic infection caused by the tapeworm Dipylidium caninum. This condition primarily affects humans, particularly children, who may become infected through the ingestion of infected fleas or contaminated food. Below is a detailed overview of the clinical description, symptoms, diagnosis, and treatment options for dipylidiasis.

Clinical Description

Etiology

Dipylidiasis is caused by the ingestion of the larval form of Dipylidium caninum, which is commonly found in fleas. The lifecycle of this tapeworm involves dogs and cats as definitive hosts, where adult worms reside in the intestines. When fleas ingest the eggs of the tapeworm, they develop into larvae, which can then be transmitted to humans, typically through accidental ingestion of infected fleas or contaminated food sources[1][2].

Symptoms

The symptoms of dipylidiasis can vary, but many infected individuals may remain asymptomatic. When symptoms do occur, they may include:

• Abdominal discomfort: Mild to moderate pain or discomfort in the abdominal area.
• Nausea and vomiting: Some patients may experience gastrointestinal upset.
• Diarrhea: Loose stools can occur, particularly in children.
• Presence of proglottids: Segments of the tapeworm may be visible in the stool, resembling grains of rice[3][4].

Diagnosis

Clinical Evaluation

Diagnosis of dipylidiasis typically involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include:

• Medical History: A thorough history to assess potential exposure to fleas or contaminated food.
• Stool Examination: Microscopic examination of stool samples can reveal the presence of proglottids or eggs, confirming the diagnosis[5].
• Imaging Studies: In some cases, imaging studies may be utilized to assess intestinal involvement, although this is less common.

Treatment

Pharmacological Interventions

The primary treatment for dipylidiasis involves the use of antiparasitic medications. Commonly prescribed medications include:

• Praziquantel: This is the most effective treatment for tapeworm infections, including dipylidiasis. It works by causing severe spasms and paralysis of the worms, allowing them to be expelled from the body.
• Niclosamide: Another option, although less commonly used, is niclosamide, which also targets tapeworms by inhibiting their ability to absorb glucose[6][7].

Prevention

Preventive measures focus on controlling flea populations in pets and maintaining good hygiene practices. Regular deworming of pets and flea control can significantly reduce the risk of transmission to humans.

Conclusion

Dipylidiasis, while often asymptomatic, can lead to gastrointestinal discomfort and other symptoms in infected individuals. Early diagnosis through stool examination and effective treatment with antiparasitic medications can manage the infection effectively. Preventive measures, particularly in households with pets, are crucial to minimize the risk of infection. For healthcare providers, awareness of this condition is essential, especially in pediatric populations where the risk of infection is higher due to behavioral factors such as hand-to-mouth activities[8].

References

1. ICD-10-CM Code for Other cestode infections B71.
2. ICD-10-CM Diagnosis Code B71.1 - Dipylidiasis.
3. ICD-10-CM Diagnosis Codes - B71 Group.
4. ICD-10-CM TABULAR LIST of DISEASES and INJURIES.
5. Article - Billing and Coding: Colonoscopy/Sigmoidoscopy.
6. 2025 ICD-10-CM Diagnosis Code B71.0: Hymenolepiasis.
7. ICD-10 International statistical classification of diseases.
8. 2025 ICD-10-CM Diagnosis Code B71.

Dipylidiasis, classified under ICD-10 code B71.1, is a parasitic infection caused by the tapeworm Dipylidium caninum. This condition primarily affects humans, particularly children, who may become infected through the ingestion of infected fleas or flea eggs. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with dipylidiasis is crucial for effective diagnosis and management.

Clinical Presentation

Signs and Symptoms

The clinical presentation of dipylidiasis can vary, but many infected individuals may be asymptomatic. When symptoms do occur, they can include:

• Abdominal Pain: Patients may experience intermittent abdominal discomfort or pain, which can be mild to moderate in intensity.
• Nausea and Vomiting: Some individuals may report feelings of nausea or may vomit, particularly in cases of heavier infestations.
• Diarrhea: Loose stools or diarrhea can occur, often accompanied by the presence of tapeworm segments in the feces.
• Weight Loss: Unintentional weight loss may be observed, especially in chronic cases where the infection persists over time.
• Itching Around the Anus: This is a common symptom due to the migration of tapeworm segments, which can irritate the perianal area.

Patient Characteristics

Dipylidiasis is more commonly seen in specific patient populations:

• Children: The majority of cases occur in children, particularly those aged 1 to 5 years, due to their higher likelihood of ingesting infected fleas during play or through poor hygiene practices.
• Pet Owners: Individuals who own pets, especially dogs and cats, are at increased risk, as these animals can harbor fleas that carry the tapeworm eggs.
• Low Socioeconomic Status: Populations with limited access to healthcare and sanitation may have higher incidences of dipylidiasis due to increased exposure to fleas and inadequate hygiene practices.

Diagnosis

Diagnosis of dipylidiasis typically involves:

• Stool Examination: Microscopic examination of stool samples can reveal the presence of tapeworm segments (proglottids) or eggs.
• Patient History: A thorough history that includes potential exposure to fleas, pets, and symptoms can aid in diagnosis.

Conclusion

Dipylidiasis, while often asymptomatic, can present with a range of gastrointestinal symptoms, particularly in children and those with pets. Awareness of the signs and symptoms, along with patient characteristics, is essential for timely diagnosis and treatment. If dipylidiasis is suspected, healthcare providers should consider stool testing and inquire about the patient's exposure to fleas and pets to confirm the diagnosis and initiate appropriate management.